Black cohosh (Actaea racemosa) for the mitigation of menopausal symptoms: Recent developments in clinical safety and efficacy

Women's Health

Volumn 2, Issue 5, 2006, Pages 773-783

  Mahady, Gail B ^a   Doyle, Brian ^a   Locklear, Tracie ^a   Cotler, Scott J ^a   Guzman Hartman, Grace ^a   Krishnaraj, Rajabather ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Black cohosh; Clinical trials estrogenic; Hepatotoxicity; Herbal; Menopause; Safety

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; ASPARTATE AMINOTRANSFERASE; CALCIUM; CHOLESTEROL; CIMICIFUGA RACEMOSA EXTRACT; DYDROGESTERONE; ESTRADIOL; FOLLITROPIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; HYPERICUM PERFORATUM EXTRACT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; OLIVE OIL; PLACEBO; PRIMROSE OIL; PROLACTIN; RALOXIFENE; SOYBEAN PROTEIN; TAMOXIFEN; VITAMIN D;

ANXIETY DISORDER; ASTHENIA; AUTOIMMUNE DISEASE; BREAST CANCER; CLINICAL TRIAL; COCHRANE LIBRARY; DATA ANALYSIS; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HOT FLUSH; HUMAN; HYSTERECTOMY; INSOMNIA; LIVER DYSFUNCTION; MEDICAL LITERATURE; MEDLINE; MENOPAUSAL SYNDROME; PATIENT COUNSELING; POSTMARKETING SURVEILLANCE; QUALITY OF LIFE; REVIEW; SWEAT GLAND DISEASE; TREATMENT OUTCOME; VAGINA ATROPHY;

EID: 33749524649     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/17455057.2.5.773     Document Type: Review

References (33)

1. Anon: WHO Annual Report 2001. WHO Publications Office, Geneva, Switzerland (2003).
2. Houmard BS, Seifer DB: Predicting the onset of menopause. In: Menopause, Endocrinology and Management. Seifer DB, Kennard EA (Eds), Humana Press, NJ, USA 1-20 (1999).
3. Mahady GB: Black cohosh (Actaea/Cimicifuga racemosa): review of the clinical data for safety and efficacy in menopausal symptoms. Treat. Endocrinol. 4(3), 177-184 (2005).
4. World Health Organization Scientific Group: Research on the menopause, WHO Technical Report Ser. 670. World Health Organization, Geneva Switzerland (1981).
5. Brosage P: Hormone therapy: the woman's decision. Contemp. Nurse Pract. S1, 3 (1995).
6. Grodstein F, Stampler MJ, Colditz GA et al.: Postmenopausal hormone therapy and mortality. N. Engl. J. Med. 336, 1769-1775 (1997).
7. Genazzani AR, Gambacciani M: International Menopause Society. Controversial issues in climacteric medicine. cardiovascular disease and hormone replacement therapy. Climacteric 3, 233-240 (2000).
8. Burkman RT, Collins JA, Greene RA: Current perspectives on benefits and risks of hormone replacement therapy. Am. J. Obstet. Gynecol. 185, S13-2S3 (2001).
9. Adams C, Cannell S: Women's beliefs about 'natural' hormones and natural hormone replacement therapy. Menopause 6, 433-440 (2001).
10. Mahady GB, Fong HHS, Farnsworth NR: Rhizoma Cimicifugae Racemosae. In: WHO Monographs on Selected Medicinal Plants. Volume II. World Health Organization, Geneva, Switzerland (2002).
11. Mahady GB, Fabricant D, Chadwick LR et al.: Black coshosh: an alternative therapy for menopause? Nutr. Clin. Care 5, 282-289 (2002).
12. Low Dog T: Menopause: a review of botanical dietary supplements. Am. J. Med. 118(12 S), 98-108 (2005).
13. Kronenberg F, Fugh-Berman A: Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern. Med. 137(10), 805-813 (2002).
14. Geller SE, Studee L: Botanical and dietary supplements for menopausal symptoms: what works, what does not. J. Women's Health 14(7), 634-649 (2005).
15. Frei-Kleiner S, Schaffner W, Rahifs VW, Bodmer CH, Birkhauser M: Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial. Maturitas 51(4), 397-404 (2005).
16. Munoz, GH, Pluchine S: Cimicifuga racemosa for the treatment of hot flashes in women surviving breast cancer. Maturitas 44(Suppl. 1). S59-S65 (2003).
17. Nappi RE, Malavasi B, Brundu B, Facchinetti F: Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol. Gynecol. Endocrinol. 20(1), 30-35 (2005).
18. Osmers R, Friede M, Liske E, Schnitker J, Freudenstein J, Henneicke-von Zepelin HH: Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet. Gynecol. 105(5 Pt 1), 1074-1083 (2005).
19. Pockaj BA, Loprinzi CL, Sloan JA et al.: Pilot evaluation of black cohosh for the treatment of hot flashes in women. Cancer Invest. 22(4), 515-521 (2004).
20. Uebelhack R, Blohmer JU, Graubaum HJ, Busch R, Gruenwald J, Wernecke KD: Black cohosh and St. John's wort for climacteric complaints: a randomized trial. Obstet. Gynecol. 107(2 Pt 1), 247-255 (2005).
21. Verhoeven MO, van der Mooren MJ, van de Weijer PH, Verdegem PJ, van der Burgt LM, Kenemans P: Effect of a combination of isoflavones and Actaea racemosa Linnaeus on climacteric symptoms in healthy symptomatic perimenopausal women: a 12-week randomized, placebo-controlled, double-blind study. Menopause 12(4), 412-420 (2005).
22. Vermes G, Banhidy F, Acs N: The effects of remifemin on subjective symptoms of menopause. Adv. Ther. 22(2). 148-154 (2005).
23. Wuttke W, Seidlova-Wuttke D, Gorkow C: The Cimicifuga preparation BNO 1055 vs conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 44(Suppl. 1), S67-S77 (2003).
24. Jacobson JS, Troxel AB, Evans J et al.: Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J. Clin. Oncol. 19, 2739-2745 (2001).
25. Mahady GB: Is black cohosh estrogenic? Nutr. Rev. 61, 183-186 (2003).
26. Minciullo PL, Saija A, Patafi M, Marotta G, Ferlazzo B, Gangemi S: Muscle damage induced by black cohosh (Cimicifuga racemosa). Phytomedicine 13(1-2), 115-118 (2006).
27. Whiting PW, Clouston A, Kerlin P: Black cohosh and other herbal remedies associated with acute hepatitis. Med. J. Australia 177, 440-443 (2002).
28. Lontos S, Jones RM, Angus PW et al.: Acute liver failure associated with the use of herbal preparations containing black cohosh. Med. J. Australia, 179, 390-391 (2003).
29. Cohen SM, O'Connor AM, Hart J et al.: Autoimmune hepatitis associated with the use of black cohosh: a case study. Menopause 11, 575-577 (2004).
30. Thomsen M, Vitetta L, Sali A: Acute liver failure associated with the use of herbal preparations containing black cohosh. Med. J. Australia 180, 598-600 (2004).
31. Levitsky J, Alli TA, Wisecarver J, Sorrell MF: Fulminant liver failure associated with the use of black cohosh. Dig. Dis. Sci. 50(3), 538-539 (2005).
32. Manns MP, Obermayer-Straub P: Cytochromes P450 and uridine triphospate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced and autoimmune liver disease. Hepatology 26, 1054-1066 (1997).
33. Beaune PH, Pessayre D, Dansette P, Mansuy D, Manns MP: Autoantibodies against cytochromes P450: role in human diseases. Adv. Pharmacol. 30, 199-245 (1994).